It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Autophagy dysfunction is one of the common causes of tumor formation and plays an important role in uveal melanoma (UM). However, little is known about the regulatory mechanisms of autophagy in UM. Here, we show that PTK6 can promote the proliferation, migration, and invasion of UM cells by inhibiting autophagy. SOCS3 can inhibit the proliferation, migration, and invasion of UM cells. Overexpression of SOCS3 can partially rescue the PTK6-induced promotion of UM cell proliferation, migration, and invasion. Mechanistically, PTK6 can bind to SOCS3, and SOCS3 can downregulate the expression of PTK6. Furthermore, PTK6 can upregulate the phosphorylation of mTOR to inhibit autophagy. Taken together, our findings demonstrate the functions of PTK6 and SOCS3 in UM cells and targeting the SOCS3-PTK6 signaling axis might be a novel and promising therapeutic strategy for patients with UM.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Wenzhou Medical University, State Key Laboratory of Ophthalmology, Optometry and Vision Science, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990); Wenzhou Medical University, The Eye Hospital, School of Ophthalmology & Optometry, Wenzhou, China (GRID:grid.268099.c) (ISNI:0000 0001 0348 3990)
2 Shanghai University of Traditional Chinese Medicine, Department of Laboratory Medicine, Longhua Hospital, Shanghai, China (GRID:grid.412540.6) (ISNI:0000 0001 2372 7462)
3 The First Affiliated Hospital of Anhui Medical University, Department of General Surgery, Hefei, China (GRID:grid.412679.f) (ISNI:0000 0004 1771 3402)
4 New York Medical College, Valhalla, Tissue Culture Center, The New York Eye and Ear Infirmary, New York, USA (GRID:grid.260917.b) (ISNI:0000 0001 0728 151X)